Codes / ICD10CM / F15.19

F15.19 Other stimulant abuse with unspecified stimulant-induced disorder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other stimulant abuse with unspecified stimulant-induced disorder (ICD-10 Code: F15.19)

Summary

This condition involves the misuse or excessive use of stimulant substances (excluding cocaine) that leads to clinically significant impairment or distress, accompanied by an unspecified stimulant-induced disorder. Stimulants increase central nervous system activity, and their abuse can result in behavioral, psychological, or physiological issues, with the specific induced disorder not further defined.

Causes

The condition is driven by intentional misuse of stimulant drugs, which may include prescription medications (e.g., amphetamines, methylphenidate) or illicit substances (e.g., methamphetamine). Prolonged or repeated non-medical use contributes to abuse patterns and the development of associated disorders.

Risk Factors

  • History of substance use or addiction.
  • High-stress environments or peer pressure.
  • Pre-existing mental health disorders (e.g., anxiety, depression).
  • Access to stimulant medications or illicit drugs.
  • Genetic or familial predisposition to substance-related issues.

Symptoms

  • Compulsive use of stimulants despite negative consequences.
  • Cravings or strong urges to use stimulants.
  • Neglect of personal, occupational, or social responsibilities.
  • Continued use despite relationship or health problems.
  • Tolerance (needing more of the substance to achieve the same effect).
  • Unspecified stimulant-induced disorder (e.g., mood, anxiety, or psychotic symptoms).

Diagnosis

Diagnosis requires a clinical evaluation of the patient’s substance use history, behavioral patterns, and associated symptoms. Healthcare providers assess for stimulant misuse and identify the presence of an unspecified stimulant-induced disorder through patient interviews, collateral information, and clinical observation.

Treatment Options

Treatment may include behavioral therapies (e.g., cognitive-behavioral therapy), medication-assisted treatment (if applicable), and support groups. Addressing the underlying stimulant-induced disorder is also a key component of care, with interventions tailored to the patient’s specific symptoms.

Prognosis and Follow-Up

Prognosis depends on the severity of abuse, presence of comorbidities, and adherence to treatment. Regular follow-up is essential to monitor for relapse, manage symptoms, and adjust interventions as needed. Long-term recovery often requires ongoing support and lifestyle modifications.

Complications

  • Worsening of stimulant-induced disorder symptoms.
  • Physical health issues (e.g., cardiovascular problems, malnutrition).
  • Social or occupational impairment.
  • Increased risk of overdose or other substance-related harm.

Lifestyle & Prevention

  • Avoid non-medical use of stimulants.
  • Seek healthy coping mechanisms for stress.
  • Maintain open communication with healthcare providers about substance use.
  • Engage in regular physical activity and balanced nutrition.
  • Build a support network to reduce relapse risk.

When to Seek Professional Help

Seek help if stimulant use is causing distress, interfering with daily life, or leading to negative consequences. Signs include loss of control over use, withdrawal symptoms, or worsening mental health.

Tips for Medical Coders

Document the presence of stimulant abuse and the unspecified stimulant-induced disorder clearly in clinical notes. Ensure the code F15.19 is used when the induced disorder is not further specified, and verify that stimulant misuse (excluding cocaine) is the primary issue. Include details on the nature of the induced disorder if available to support coding accuracy.

Medical Policies and Guidelines

Related policies from health plans